切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 86 -92. doi: 10.3877/cma.j.issn.1674-3903.2021.02.005

论著

供受者预测心脏质量对成人心脏移植近中期预后的影响
刘星1, 熊倜修思1, 孙永丰1, 董念国1, 史嘉玮1,()   
  1. 1. 430022 武汉,华中科技大学同济医学院附属协和医院心脏大血管外科
  • 收稿日期:2020-12-10 出版日期:2021-04-25
  • 通信作者: 史嘉玮
  • 基金资助:
    国家自然科学基金(81770387); 国家重点研发计划(2016YFA0101100)

Impact of donor-recipient predicted heart mass on short to mid-term prognosis after adult heart transplantation

Xing Liu1, Tixiusi Xiong1, Yongfeng Sun1, Nianguo Dong1, Jiawei Shi1,()   

  1. 1. Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
  • Received:2020-12-10 Published:2021-04-25
  • Corresponding author: Jiawei Shi
引用本文:

刘星, 熊倜修思, 孙永丰, 董念国, 史嘉玮. 供受者预测心脏质量对成人心脏移植近中期预后的影响[J]. 中华移植杂志(电子版), 2021, 15(02): 86-92.

Xing Liu, Tixiusi Xiong, Yongfeng Sun, Nianguo Dong, Jiawei Shi. Impact of donor-recipient predicted heart mass on short to mid-term prognosis after adult heart transplantation[J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(02): 86-92.

目的

探讨供受者预测心脏质量(PHM)匹配对成人(≥18岁)心脏移植术后近中期预后的影响。

方法

回顾性分析2015年1月至2019年12月在华中科技大学同济医学院附属协和医院心脏大血管外科接受原位心脏移植的成人受者临床资料。供受者PHM相对差异>15%纳入供心过小组;供受者PHM相对差异绝对值≤15%纳入供心匹配组;供受者PHM相对差异<-15%纳入供心过大组。观察和比较供心过大组、匹配组和过小组间基线资料、供受者匹配资料、围手术期资料和心脏移植术后近中期预后情况。采用Kruskal-Wallis H检验比较三组间非正态分布计量资料。采用卡方检验或Fisher确切概率法比较三组间计数资料。采用Spearman秩相关分析法分析供受者PHM相对差异与供受者身高和体质量相对差异相关性。采用Kaplan-Meier法绘制三组受者术后1年生存曲线并采用log-rank检验进行比较。采用单因素Cox比例风险模型评估供受者PHM匹配类型和协变量与移植后1年死亡风险的关联。P<0.05为差异有统计学意义。

结果

最终纳入409例心脏移植受者,其中供心过小组57例,供心匹配组248例,供心过大组104例。三组供受者性别以及受者身高、体质量、血红蛋白、血清肌酐、左心房内径和左心室内径差异均有统计学意义(χ2=70.396和124.77,H=95.609、127.251、20.551、10.557、10.048和16.829,P均<0.05)。三组供受者PHM相对差异、体质量相对差异、身高相对差异及供受者性别匹配差异均有统计学意义(H=309.231、198.337和175.310, χ2=288.827,P均<0.05)。供受者PHM相对差异与供受者体质量和身高相对差异均显著相关(r=0.863和0.720,P均<0.05)。三组受者术后IABP使用比例和呼吸系统并发症发生率以及术后3周左心房和右心房内径差异均有统计学意义(χ2=6.619和6.313,H=12.915和10.727,P均<0.05)。供心过大组、供心匹配组和供心过小组受者术后1年累积生存率分别为84.6%、84.5%和93.0%,差异无统计学意义(χ2=2.998,P>0.05)。Cox比例风险模型单因素分析结果表明,受者术前血红蛋白、血清肌酐、左心室内径和年龄是受者术后1年死亡影响因素(HR=0.980、1.004、0.831和1.036,P均<0.05);Cox比例风险模型多因素分析结果显示受者术前血红蛋白和左心室内径均为受者术后1年死亡的独立保护因素(HR=0.982和0.839,P均<0.05),受者年龄和术前总胆红素均为独立危险因素(HR=1.048和1.017,P均<0.05)。

结论

心脏移植供受者PHM匹配对受者术后1年生存率无显著影响,受者术前血红蛋白和左心室内径是其术后1年死亡的独立保护因素,年龄和总胆红素是其术后1年死亡的独立危险因素。

Objective

To exploring the impact of donor-recipient predicted heart mass (PHM) matching on short to mid-term prognosis of adult (≥18 years old) heart transplantation.

Methods

The clinical data of adult patients who received orthotopic heart transplantation in the Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology from 2015 to 2019 were retrospectively analyzed. The recipients whose donor-recipient PHM relative differences were greater than 15%, were classified into the oversized group; those whose donor-recipient PHM relative differences were less than -15%, were classified into the undersized group; the others whose absolute value of donor-recipient PHM relative differences were within 15%, were classified into the matched group. The baseline data, perioperative data, matching data of donor and recipient, perioperative data and prognosis among the three groups were compared. The non-normal distribution measurement data among the three groups were compared by Kruskal-Wallis H test. The enumeration data among the three groups were compared by chi-square test or Fisher′s exact probability method. The Spearman rank correlation analysis method was used to analyse the correlation between PHM relative difference and height or weight relative difference. The Kaplan-Meier method was used to draw the postoperative 1-year survival curve of the three groups and the postoperative 1-year survival rate among the three groups was compared with log-rank test. Univariate and multivariate Cox proportional hazards model was used to evaluate the association between different PHM types and covariates and the risk of death at 1 year after transplantation. P<0.05 was considered statistically significant.

Results

Four hundred and nine heart transplantation recipients were included, of which 57 were in the donor undersized group, 248 were in the donor matched group, and 104 were in the donor oversized group. The difference of gender of donors and recipients, and height, weight, preoperative hemoglobin, preoperative serum creatinine, left atrial diameter and left ventricular internal diameter of recipients among the three groups were statistically significant (χ2=70.396 and 124.77, H=95.609, 127.251, 20.551, 10.557, 10.048 and 16.829, all P <0.05). The difference of relative difference in PHM, weight, height, donor-recipient gender matching among the three groups were statistically significant (H=309.231, 198.337 and 175.310, χ2=288.827, P all <0.05). The relative difference in PHM was significantly related to the relative difference in weight and height (r=0.863 and 0.720, all P<0.05). The difference of postoperative IABP usage rate, incidience of respiratory complications, left atrial and right atrium diameter of recipients among the three groups were statistical difference significant (χ2=6.619 and 6.313, H=12.915 and 10.727, all P<0.05). The 1-year cumulative survival rates of the donor oversized group, the matched group, and the donor undersized group were 84.6%, 84.5%, and 93%, respectively, which were not statistically significant (χ2=2.998, P>0.05). The results of univariate Cox proportional hazards model showed that preoperative hemoglobin, serum creatinine, left ventricular internal diameter and age of recipients had strong effect on 1 year death rate (HR=0.980, 1.004, 0.831 and 1.036, all P<0.05). The results of multivariate Cox proportional hazards model showed that preoperative hemoglobin and left ventricular internal diameter of recipients were the independent protective factors for 1 year death rate (HR=0.982 and 0.839, all P<0.05), and the age and preoperative total bilirubin were the independent risk factors (HR=1.048 and 1.017, all P<0.05).

Conclusions

The different type of donor-recipient PHM matching has no significant effect on the 1 year death rate after heart transplantation, and preoperative hemoglobin and left ventricular internal diameter were the independent protective factors for 1 year death rate, and age and total bilirubin of recipients were the independent risk factors for 1 year death rate.

表1 供心过大组、匹配组和过小组供受者心脏移植术前一般资料比较
表2 供心过大、匹配组和过小组供受者匹配信息比较
图1 供受者PHM相对差异与供受者身高和体质量相对差异的相关性分析
表3 供心过大组、匹配组和过小组受者围手术期资料比较
图2 供心过大组、匹配组和过小组术后1年生存曲线
表4 心脏移植受者术后1年死亡危险因素Cox比例风险模型分析
1
Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients[J]. J Heart Lung Transplant, 2010, 29(8): 914-956.
2
Bergenfeldt H, Stehlik J, Hoglund P, et al. Donor-recipient size matching and mortality in heart transplantation: Influence of body mass index and gender[J]. J Heart Lung Transplant, 2017, 36(9): 940-947.
3
Reed RM, Netzer G, Hunsicker L, et al. Cardiac size and sex-matching in heart transplantation : size matters in matters of sex and the heart[J]. JACC Heart Fail, 2014, 2(1): 73-83.
4
Kransdorf EP, Kittleson MM, Benck LR, et al. Predicted heart mass is the optimal metric for size match in heart transplantation[J]. J Heart Lung Transplant, 2019, 38(2): 156-165.
5
Gong TA, Joseph SM, Lima B, et al. Donor predicted heart mass as predictor of primary graft dysfunction[J]. J Heart Lung Transplant, 2018, 37(7): 826-835.
6
Shah M, Saeed O, Shin J, et al. Predicted heart mass-based size matching among recipients with moderate pulmonary hypertension: outcomes and sex effect[J]. J Heart Lung Transplant, 2020, 39(7): 648-656.
7
Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38(10):1056-1066.
8
Patel ND, Weiss ES, Nwakanma LU, et al. Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database[J]. Circulation, 2008, 118(Suppl 14): S83-S88.
9
Kawut SM, Lima JA, Barr RG, et al. Sex and race differences in right ventricular structure and function: the multi-ethnic study of atherosclerosis-right ventricle study[J]. Circulation, 2011, 123(22): 2542-2551.
10
Bluemke DA, Kronmal RA, Lima JA, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study[J]. J Am Coll Cardiol, 2008, 52(25): 2148-2155.
11
Dewey FE, Rosenthal D, Murphy DJ Jr, et al. Does size matter? Clinical applications of scaling cardiac size and function for body size[J]. Circulation, 2008, 117(17): 2279-2287.
12
Weiss ES, Allen JG, Kilic A, et al. Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation[J]. J Heart Lung Transplant, 2012, 31(3): 266-273.
13
Kilic A, Allen JG, Weiss ES. Validation of the United States-derived index for mortality prediction after cardiac transplantation (IMPACT) using international registry data[J]. J Heart Lung Transplant, 2013, 32(5): 492-498.
14
Taylor DO, Stehlik J, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth official adult heart transplant report-2009[J]. J Heart Lung Transplant, 2009, 28(10): 1007-1022.
15
Joyce DL, Li Z, Edwards LB, et al. Predicting 1-year cardiac transplantation survival using a donor-recipient risk-assessment tool[J]. J Thorac Cardiovasc Surg, 2018, 155(4): 1580-1590.
[1] 蒋春艳, 赵刚, 诸国萍, 付庆辉, 卫建华. 等待心脏移植患者术前行右心漂浮导管检查临床应用及护理策略分析[J]. 中华移植杂志(电子版), 2023, 17(03): 164-168.
[2] 滕鹏, 郑骏楠, 郭雷, 胡鹏, 倪程耀, 赵海格, 马量. 心脏移植术前体外膜肺氧合循环辅助桥接33例疗效分析[J]. 中华移植杂志(电子版), 2022, 16(06): 339-345.
[3] 任明仕, 王明岩, 董士勇, 彭江, 申华, 刘冰, 崔梦一, 成楠, 刘博罕, 邱实, 张涛, 任延玲, 魏红江, 宋翔宇, 杨博尧, 王凯, 熊兴, 王嵘. 人源化基因修饰猪-猴异种心脏移植的实验研究[J]. 中华移植杂志(电子版), 2022, 16(06): 329-338.
[4] 陈善良, 赵霜梅, 许莉, 厉泉, 苗强, 李敏, 李红昕, 刘天起. 心脏移植术后人类微小病毒B19感染致纯红细胞再生障碍性贫血三例并文献复习[J]. 中华移植杂志(电子版), 2022, 16(05): 299-301.
[5] 郑珊珊, 郑哲, 黄洁, 廖中凯, 宋云虎, 房晓楠, 刘盛. 主动脉内球囊反搏作为心脏移植桥接治疗对晚期心力衰竭合并肺动脉高压患者的疗效[J]. 中华移植杂志(电子版), 2022, 16(05): 277-284.
[6] 杨守国. 心脏移植术后抗体介导排斥反应研究现况与进展[J]. 中华移植杂志(电子版), 2022, 16(05): 266-276.
[7] 刘长, 刘达兴. 心脏移植物血管病的临床研究进展[J]. 中华移植杂志(电子版), 2022, 16(04): 241-248.
[8] 童路, 苏伟, 孙永丰, 张菁, 董念国, 史嘉玮. 延迟关胸在儿童心脏移植中的应用[J]. 中华移植杂志(电子版), 2022, 16(02): 83-87.
[9] 杨锦然, 李新长, 傅俊, 杨华, 张友福, 龙成美. 猪-人异种心脏移植展望[J]. 中华移植杂志(电子版), 2021, 15(06): 375-382.
[10] 冯春蕾, 黄洁. 心脏移植相关非甲状腺性病态综合征与甲状腺激素替代治疗[J]. 中华移植杂志(电子版), 2021, 15(05): 313-316.
[11] 吴智勇, 左一凡, 王志维, 阮永乐, 任宗力, 任伟, 胡锐, 余岸峰, 石烽. 心脏移植术后死亡危险因素分析[J]. 中华移植杂志(电子版), 2021, 15(05): 270-275.
[12] 左一凡, 吴琪, 王志维. 哺乳动物雷帕霉素靶蛋白抑制剂在心脏移植中的应用研究进展[J]. 中华移植杂志(电子版), 2021, 15(04): 250-256.
[13] 郑珊珊, 唐汉韡, 黄洁, 廖仲恺, 郑哲, 宋云虎, 刘盛. 两种国际心脏移植风险评分模型在阜外医院心脏移植人群的适用性评价[J]. 中华移植杂志(电子版), 2021, 15(03): 129-135.
[14] 吴红兵, 王志维, 任宗力, 李罗成, 吴智勇, 石烽, 胡俊霞. 连续70例原位心脏移植无院内死亡经验总结[J]. 中华移植杂志(电子版), 2021, 15(03): 166-168.
[15] 黄文, 王海燕, 徐瑞. 超声心动图评估心脏移植患者术前肺动脉压力对术后早期右心功能的影响[J]. 中华诊断学电子杂志, 2021, 09(04): 221-225.
阅读次数
全文


摘要